RE:2 weeks to lift offI too have become critical of managements ability to lead this company. The lack of transparency affects credibility. Well over a year after the formation of the Scientific Advisory Board and hiring of Dash Consulting, zero progress has been shared. Formula Development for the 5 Health Canada Approvals has taken much to long and with zero explaination. Zero news after the PP as to what the funds have been allocated for. FDA meeting was set for June 2022 after which regulatory submissions was supposed to happen, yet no news on this front. Management has over hyped and under performed.
IMO, shareholders should be seriously concerned as management continously leaves share holders in the dark.